Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung CancerBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaLung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerGRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) TherapyStudy of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal RingRadiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent SurgeryPatient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerMaintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaThird International Study on Mechanical VentilationREASSURE AV RegistryPaclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerObservation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node DissectionEffect of Remote Ischemic Preconditioning on Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft SurgeryTicagrelor in Severe Community Acquired PneumoniaA Randomized Trial of Outpatient Oxygen Weaning Strategies in Premature InfantsSargramostim and/or Vaccine Therapy in Preventing Disease Recurrence in Patients With Advanced MelanomaParturient Controlled Epidural Analgesia (PCEA) With or Without a Basal Infusion for Early LaborCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaInternational PFO ConsortiumHostDx Sepsis in Patients With Acute Respiratory InfectionsNicotine Replacement Treatment for Pregnant Smokers - 1Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaPexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically RemovedCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgeryDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerSafety and Performance of Muscle Activation for Critical Care PatientsAzacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaMinocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac SurgeryRituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell LymphomaComparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair MeshCombination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing SarcomaBlood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung CancerA Trial of Tisotumab Vedotin in Cervical Cancer
P6153
Q42174079-1EE6D1AB-791E-4B16-83A0-9D14E87CBE20Q45352171-9063E112-E872-4898-8611-2FAC39D5AED5Q55426362-60E2B58A-855F-4D83-9F4D-80817AB1B2E6Q58214768-A03C19E8-80A3-4155-8EF0-3516AD037BB3Q59696621-ED37CDF9-3B7C-405E-BCA2-FB8AEB5ABE7BQ60056193-D5EAEEBF-F419-422B-859E-DCB504CFB029Q60313129-61CD5CF4-DE58-4E52-A7CF-8D999171B9F5Q83285502-EE93C517-ED75-48B2-B26D-88D84A9EA34EQ85681579-04A9EDDF-42B5-4591-A150-426A10F0A19BQ86593413-3914CC53-79AA-4E2A-915F-0A33DEEB2749Q87653015-93A54F2A-67E7-4E92-A8ED-2517D4AA2DCCQ87974302-DA696385-3A38-4103-ACD3-F00A70F93C0DQ88776357-FBB293B5-E706-4079-B92B-729155CC4861Q89209285-7EC765E3-E2B8-44F2-824B-791E69F921E2Q89504504-3EBB9E70-2F91-4F67-88AA-5C192489F95D
P108
Q58407878-C95F7866-7060-4BAB-8B95-86C53A779E61Q58845627-5F136570-2745-4677-935A-4221E2E2BE0BQ58846742-F04EEB2B-F34A-4001-ACE2-6FED45ACBBAAQ61864749-651B24C5-B170-47C0-AC3C-C8473E9A3A57Q61865593-DC1F00F0-4783-4ECB-97CB-1ADD18ED51AAQ61914386-BBDA6D4E-5DCF-4D90-826F-07AD753F7885Q61917783-EAB05DE6-7A0C-485A-A922-6BB4963CE901Q61920653-B05CC80F-C792-4404-B6D9-0E3E8D4F57D5Q61936010-EB0AA0FC-1071-42B7-9716-657648D7AFBDQ61936299-CF74CDAE-2BC1-4F4E-A5DA-CD6FD405094DQ61936459-CF866AAD-BCDA-41A9-BF52-72CC10FE78E8Q61936877-90B9E800-08F6-4FCC-8B2F-BF033C0991D8Q61938395-E6327E9B-E9B9-4E38-995F-53FC8964F021Q61955911-49D4A812-FEBB-4198-B936-F1D122501B54Q61957712-B1BD8E8B-3080-4CAF-9D1E-0555D2349B92Q61957727-3FF2270A-424F-45C7-A689-4C98795F7927Q61969449-701450A2-4A83-4C7A-B015-95A0037DA57DQ61969728-55A9368E-3E89-4E71-9C28-860ABFE4E6FFQ61970163-A17B7FE0-9884-49CE-84F8-7EFE84DBF6EBQ61980565-F691BE48-93CF-42AE-A689-DCB77EF66049Q61980943-16E71690-CE59-400D-B2FB-894195A5F295Q61981566-30C3FDCF-BE01-4D41-9960-814A04D332B1Q62034558-42E2300E-D24F-446B-B5E9-BCB21066D885Q62104730-8C055B70-B22E-4399-B880-FC99D419CD63Q62105330-45A31D33-2559-4576-9FB5-31C6137CB476Q62105570-98E38F2D-519C-4F34-84F1-447BF1062CE7Q62105597-D84B8D0E-9457-4C1C-AF18-AFD8C1171950Q62106060-2A447541-672D-491E-90B8-FF7F9F95B370Q62110268-5D8D55CE-D8FC-4B4F-A5D6-559B7BE6F3DDQ62111035-A50E29B3-289E-4C74-AE33-1F7DD96F4849Q62815257-97BEAE89-DB6F-4CCE-8EB7-5AC2EF763BDDQ63316568-69E2BADD-C110-4171-A57C-04756E1A633BQ63319491-57503141-89B3-42A3-BA52-85DC4A04DFD2Q63319699-9A25D7B2-3947-4003-811A-C363C02BB2B3Q63321941-6A73B3EA-84E1-469D-9A13-CF3228D5C0DAQ63322920-794E1474-40F7-42AC-820D-B7F50F32CC26Q63336981-1C07DE48-4718-4C76-BAB4-87878D40CCC6Q63341046-D1CEAEDF-C31B-4982-A722-B1BF0A8DB552Q63394599-52F99AB4-D4B1-473B-BA73-1977CC628E69Q63401543-0C6C7F7D-AA1D-4B23-A3C2-175579ECC099
P6153
description
americká firma
@cs
bedrijf uit Verenigde Staten van Amerika
@nl
name
Baystate Medical Center
@en
Baystate Medical Center
@fr
type
label
Baystate Medical Center
@en
Baystate Medical Center
@fr
altLabel
Springfield Hospital
@en
prefLabel
Baystate Medical Center
@en
Baystate Medical Center
@fr
P1566
P214
P244
P6366
P1566
P159
P213
0000 0004 0433 813X
P214
P2427
grid.281162.e
P244
P3500
P6366
1338449461
P6782
P7859
lccn-n85188902